Global Organ Transplant Immunosuppressant Drugs Market Report 2024

Organ Transplant Immunosuppressant Drugs Global Market Report 2023 – By Drug Class (Calcineurin Inhibitors, Antiproliferative Agents, mTOR Inhibitor, Steroids, Others Drug Classes), By Transplant Type (Heart, Kidney, Liver, Lung, Pancreas, Other Transplant Types), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) – Market Size, Trends, And Global Forecast 2023-2032

Starting Price : $5000.00 | Pages : 175 | Published : July 2023 | Delivery Time: 2-3 business days | Format : pdf

Need assistance or more information before the purchase?

Enquire Before Buying
Organ Transplant Immunosuppressant Drugs Global Market Report 2023

Proud Members Of

checkslacipN checkaoirsN checkscipN

Neuromodulation is the modification of nerve activity (or modulation) by delivering electrical or pharmacological substances directly to a specific location. It is a reversible procedure performed to relieve pain.

Organ transplant immunosuppressant drugs are medications used to suppress the immune system of a transplant recipient to prevent rejection of the transplanted organ.

The main classes of organ transplant immunosuppressant drugs are calcineurin inhibitors, antiproliferative agents, motor inhibitor, steroids, and others. Calcineurin is an enzyme that plays a vital role in activating T-cells, immune cells that can attack transplanted organs. Calcineurin inhibitors are immunosuppressant drugs that are used to prevent organ rejection in patients receiving organ transplants. It is used in transplant of heart, kidney, liver, lung, pancreas, and others and distributed through hospital pharmacies, retail pharmacies, and online pharmacies.

The global organ transplant immunosuppressant drugs market is segmented -

1) By Drug Class: Calcineurin Inhibitors, Antiproliferative Agents, mTOR Inhibitor, Steroids, Others Drug Classes

2) By Transplant Type: Heart, Kidney, Liver, Lung, Pancreas, Other Transplant Types

3) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

The global organ transplant immunosuppressant drugs market size is expected to grow from $5.03 billion in 2022 to $5.24 billion in 2023 at a compound annual growth rate (CAGR) of 3.08%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The global organ transplant immunosuppressant drugs market size is expected to reach $6.00 billion in 2027 at a CAGR of 3.44%.

The increasing demand for organ transplantation will boost the organ transplant immunosuppressant drugs market. Organ transplantation is a surgical procedure in which a diseased or damaged organ in a person's body is replaced with a healthy organ from a donor. Organ transplantation is a life-saving procedure that replaces damaged or failed organs with healthy organs from a donor. Immunosuppressant drugs are essential to prevent the rejection of transplanted organs, which can lead to organ rejection. The availability and effectiveness of immunosuppressant drugs are essential for the success of organ transplantation. For instance, in 2021, as per the data from the Global Observatory on Donation and Transplantation (GODT), an international organisation, 144,302 organs were transplanted annually in 2021, an 11.3% increase over 2020. Therefore, the increasing demand for organ transplantation will drive the organ transplant immunosuppressant drugs market forward.

Major players in the organ transplant immunosuppressant drugs market are Astellas Pharma Inc., F. Hoffmann-La Roche AG, Novartis AG, Accord Healthcare Limited, GlaxoSmithKline PLC., Pfizer Inc., Sanofi S.A., Alsachim a Shimadzu Group Company, Neovii Pharmaceuticals AG, Zydus Lifesciences Limited, Dr. Reddy’s Laboratories Ltd., Lupin Limited, Mylan Laboratories Inc., Strides Pharma Global Pte Ltd., and Asahi Kasei Corporation.

Product innovation is a popular trend in the organ transplant immunosuppressant drugs market. Major companies operating in organ transplant immunosuppressant drugs focusing on developing innovative solutions, such as combination therapy, to sustain in the market. Combination therapy involving two or more immunosuppressant drugs is becoming more common, as it can provide greater immunosuppression while reducing the risk of side effects. For instance, in July 2021, the U.S. Food and Drug Administration (FDA), a federal agency of the Department of Health and Human service, approved Prograf for use in combination with other immunosuppressant drugs for the prevention of organ rejection in patients receiving kidney, liver, or heart transplants. Prograf is an immunosuppressant, which was initially licensed to prevent organ rejection in patients undergoing liver transplants, later approved to prevent organ rejection in patients receiving kidney and heart transplants as well.

In September 2021, Sanofi S.A., a France-based pharmaceutical and healthcare company, acquired Kadmon Holdings for approximately $1.9 billion. Sanofi's acquisition aims to expand its transplant business and pipeline by adding Kadmon’s immunosuppressant drug, Rezurock, which the US FDA recently approved for treating chronic graft-versus-host disease (cGVHD). Kadmon Holdings Inc. is a US-based biopharmaceutical firm that operates in organ transplant immunosuppressant drugs.

North America was the largest region in the organ transplant immunosuppressant drugs market in 2022. Asia-Pacific is expected to be the fastest-growing region in the global organ transplant immunosuppressant drugs market report during the forecast period. The regions covered in the global organ transplant immunosuppressant drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the organ transplant immunosuppressant drugs market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.

The organ transplant immunosuppressant drugs market consists of sales of drugs such asteroid-sparing immunosuppressants, prednisone, antineoplastics, monoclonal antibody drug, and immunosuppressive agents. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

The organ transplant immunosuppressant drugs market research report is one of a series of new reports from The Business Research Company that provides organ transplant immunosuppressant drugs market statistics, including organ transplant immunosuppressant drugs industry global market size, regional shares, competitors with an organ transplant immunosuppressant drugs market share, detailed organ transplant immunosuppressant drugs market segments, market trends and opportunities, and any further data you may need to thrive in the organ transplant immunosuppressant drugs industry. This organ transplant immunosuppressant drugs market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

    Table Of Contents

    1. Executive Summary

    2. Organ Transplant Immunosuppressant Drugs Market Characteristics

    3. Organ Transplant Immunosuppressant Drugs Market Trends And Strategies

    4. Organ Transplant Immunosuppressant Drugs Market - Macro Economic Scenario

    4.1. COVID-19 Impact On Organ Transplant Immunosuppressant Drugs Market

    4.2. Ukraine-Russia War Impact On Organ Transplant Immunosuppressant Drugs Market

    4.3. Impact Of High Inflation On Organ Transplant Immunosuppressant Drugs Market

    5. Organ Transplant Immunosuppressant Drugs Market Size And Growth

    5.1. Global Organ Transplant Immunosuppressant Drugs Historic Market, 2017-2022, $ Billion

    5.1.1. Drivers Of The Market

    5.1.2. Restraints On The Market

    5.2. Global Organ Transplant Immunosuppressant Drugs Forecast Market, 2022-2027F, 2032F, $ Billion

    5.2.1. Drivers Of The Market

    5.2.2. Restraints On the Market

    6. Organ Transplant Immunosuppressant Drugs Market Segmentation

    6.1. Global Organ Transplant Immunosuppressant Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    Calcineurin Inhibitors

    Antiproliferative Agents

    mTOR Inhibitor

    Steroids

    Others Drug Classes

    6.2. Global Organ Transplant Immunosuppressant Drugs Market, Segmentation By Transplant Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    Heart

    Kidney

    Liver

    Lung

    Pancreas

    Other Transplant Types

    6.3. Global Organ Transplant Immunosuppressant Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    Hospital Pharmacies

    Retail Pharmacies

    Online Pharmacies

    7. Organ Transplant Immunosuppressant Drugs Market Regional And Country Analysis

    7.1. Global Organ Transplant Immunosuppressant Drugs Market, Split By Region, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    7.2. Global Organ Transplant Immunosuppressant Drugs Market, Split By Country, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    8. Asia-Pacific Organ Transplant Immunosuppressant Drugs Market

    8.1. Asia-Pacific Organ Transplant Immunosuppressant Drugs Market Overview

    Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

    8.2. Asia-Pacific Organ Transplant Immunosuppressant Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    8.3. Asia-Pacific Organ Transplant Immunosuppressant Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    9. China Organ Transplant Immunosuppressant Drugs Market

    9.1. China Organ Transplant Immunosuppressant Drugs Market Overview

    9.2. China Organ Transplant Immunosuppressant Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F,$ Billion

    9.3. China Organ Transplant Immunosuppressant Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F,$ Billion

    10. India Organ Transplant Immunosuppressant Drugs Market

    10.1. India Organ Transplant Immunosuppressant Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    10.2. India Organ Transplant Immunosuppressant Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    11. Japan Organ Transplant Immunosuppressant Drugs Market

    11.1. Japan Organ Transplant Immunosuppressant Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    11.2. Japan Organ Transplant Immunosuppressant Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    12. Australia Organ Transplant Immunosuppressant Drugs Market

    12.1. Australia Organ Transplant Immunosuppressant Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    12.2. Australia Organ Transplant Immunosuppressant Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    13. Indonesia Organ Transplant Immunosuppressant Drugs Market

    13.1. Indonesia Organ Transplant Immunosuppressant Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    13.2. Indonesia Organ Transplant Immunosuppressant Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    14. South Korea Organ Transplant Immunosuppressant Drugs Market

    14.1. South Korea Organ Transplant Immunosuppressant Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    14.2. South Korea Organ Transplant Immunosuppressant Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    15. Western Europe Organ Transplant Immunosuppressant Drugs Market

    15.1. Western Europe Organ Transplant Immunosuppressant Drugs Market Overview

    15.2. Western Europe Organ Transplant Immunosuppressant Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    15.3. Western Europe Organ Transplant Immunosuppressant Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    16. UK Organ Transplant Immunosuppressant Drugs Market

    16.1. UK Organ Transplant Immunosuppressant Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    16.2. UK Organ Transplant Immunosuppressant Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    17. Germany Organ Transplant Immunosuppressant Drugs Market

    17.1. Germany Organ Transplant Immunosuppressant Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    17.2. Germany Organ Transplant Immunosuppressant Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    18. France Organ Transplant Immunosuppressant Drugs Market

    18.4. France Organ Transplant Immunosuppressant Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    18.5. France Organ Transplant Immunosuppressant Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    19. Eastern Europe Organ Transplant Immunosuppressant Drugs Market

    19.1. Eastern Europe Organ Transplant Immunosuppressant Drugs Market Overview

    19.2. Eastern Europe Organ Transplant Immunosuppressant Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    19.3. Eastern Europe Organ Transplant Immunosuppressant Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    20. Russia Organ Transplant Immunosuppressant Drugs Market

    20.1. Russia Organ Transplant Immunosuppressant Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    20.2. Russia Organ Transplant Immunosuppressant Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    21. North America Organ Transplant Immunosuppressant Drugs Market

    21.1. North America Organ Transplant Immunosuppressant Drugs Market Overview

    21.2. North America Organ Transplant Immunosuppressant Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    21.3. North America Organ Transplant Immunosuppressant Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    22. USA Organ Transplant Immunosuppressant Drugs Market

    22.1. USA Organ Transplant Immunosuppressant Drugs Market Overview

    22.2. USA Organ Transplant Immunosuppressant Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    22.3. USA Organ Transplant Immunosuppressant Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    23. South America Organ Transplant Immunosuppressant Drugs Market

    23.1. South America Organ Transplant Immunosuppressant Drugs Market Overview

    23.2. South America Organ Transplant Immunosuppressant Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    23.3. South America Organ Transplant Immunosuppressant Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    24. Brazil Organ Transplant Immunosuppressant Drugs Market

    24.1. Brazil Organ Transplant Immunosuppressant Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    24.2. Brazil Organ Transplant Immunosuppressant Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    25. Middle East Organ Transplant Immunosuppressant Drugs Market

    25.1. Middle East Organ Transplant Immunosuppressant Drugs Market Overview

    25.2. Middle East Organ Transplant Immunosuppressant Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    25.3. Middle East Organ Transplant Immunosuppressant Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    26. Africa Organ Transplant Immunosuppressant Drugs Market

    26.1. Africa Organ Transplant Immunosuppressant Drugs Market Overview

    26.2. Africa Organ Transplant Immunosuppressant Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    26.3. Africa Organ Transplant Immunosuppressant Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    27. Organ Transplant Immunosuppressant Drugs Market Competitive Landscape And Company Profiles

    27.1. Organ Transplant Immunosuppressant Drugs Market Competitive Landscape

    27.2. Organ Transplant Immunosuppressant Drugs Market Company Profiles

    27.2.1. Astellas Pharma US, Inc.

    27.2.1.1. Overview

    27.2.1.2. Products and Services

    27.2.1.3. Strategy

    27.2.1.4. Financial Performance

    27.2.2. F. Hoffmann-La Roche AG

    27.2.2.1. Overview

    27.2.2.2. Products and Services

    27.2.2.3. Strategy

    27.2.2.4. Financial Performance

    27.2.3. Novartis AG

    27.2.3.1. Overview

    27.2.3.2. Products and Services

    27.2.3.3. Strategy

    27.2.3.4. Financial Performance

    27.2.4. Accord Healthcare Limited

    27.2.4.1. Overview

    27.2.4.2. Products and Services

    27.2.4.3. Strategy

    27.2.4.4. Financial Performance

    27.2.5. GlaxoSmithKline plc.

    27.2.5.1. Overview

    27.2.5.2. Products and Services

    27.2.5.3. Strategy

    27.2.5.4. Financial Performance

    28. Key Mergers And Acquisitions In The Organ Transplant Immunosuppressant Drugs Market

    29. Organ Transplant Immunosuppressant Drugs Market Future Outlook and Potential Analysis

    30. Appendix

    30.1. Abbreviations

    30.2. Currencies

    30.3. Historic And Forecast Inflation Rates

    30.4. Research Inquiries

    30.5. The Business Research Company

    30.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2017-2022, $ Billion
  • Table 2: Global Forecast Market Growth, 2022-2027F, 2032F, $ Billion
  • Table 3: Global Organ Transplant Immunosuppressant Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 4: Global Organ Transplant Immunosuppressant Drugs Market, Segmentation By Transplant Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 5: Global Organ Transplant Immunosuppressant Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 6: Global Organ Transplant Immunosuppressant Drugs Market, Split By Region, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 7: Global Organ Transplant Immunosuppressant Drugs Market, Split By Country, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 8: Asia-Pacific, Organ Transplant Immunosuppressant Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 9: Asia-Pacific, Organ Transplant Immunosuppressant Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 10: China, Organ Transplant Immunosuppressant Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 11: China, Organ Transplant Immunosuppressant Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 12: India, Organ Transplant Immunosuppressant Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 13: India, Organ Transplant Immunosuppressant Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 14: Japan, Organ Transplant Immunosuppressant Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 15: Japan, Organ Transplant Immunosuppressant Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 16: Australia, Organ Transplant Immunosuppressant Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 17: Australia, Organ Transplant Immunosuppressant Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 18: Indonesia, Organ Transplant Immunosuppressant Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 19: Indonesia, Organ Transplant Immunosuppressant Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 20: South Korea, Organ Transplant Immunosuppressant Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 21: South Korea, Organ Transplant Immunosuppressant Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 22: Western Europe, Organ Transplant Immunosuppressant Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 23: Western Europe, Organ Transplant Immunosuppressant Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 24: UK, Organ Transplant Immunosuppressant Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 25: UK, Organ Transplant Immunosuppressant Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 26: Germany, Organ Transplant Immunosuppressant Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 27: Germany, Organ Transplant Immunosuppressant Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 28: France, Organ Transplant Immunosuppressant Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 29: France, Organ Transplant Immunosuppressant Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 30: Eastern Europe, Organ Transplant Immunosuppressant Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 31: Eastern Europe, Organ Transplant Immunosuppressant Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 32: Russia, Organ Transplant Immunosuppressant Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 33: Russia, Organ Transplant Immunosuppressant Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 34: North America, Organ Transplant Immunosuppressant Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 35: North America, Organ Transplant Immunosuppressant Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 36: USA, Organ Transplant Immunosuppressant Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 37: USA, Organ Transplant Immunosuppressant Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 38: South America, Organ Transplant Immunosuppressant Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 39: South America, Organ Transplant Immunosuppressant Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 40: Brazil, Organ Transplant Immunosuppressant Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 41: Brazil, Organ Transplant Immunosuppressant Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 42: Middle East, Organ Transplant Immunosuppressant Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 43: Middle East, Organ Transplant Immunosuppressant Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 44: Africa, Organ Transplant Immunosuppressant Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 45: Africa, Organ Transplant Immunosuppressant Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 46: Astellas Pharma US, Inc. Financial Performance
  • Table 47: F. Hoffmann-La Roche AG Financial Performance
  • Table 48: Novartis AG Financial Performance
  • Table 49: Accord Healthcare Limited Financial Performance
  • Table 50: GlaxoSmithKline plc. Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2017-2022, $ Billion
  • Figure 2: Global Forecast Market Growth, 2022-2027F, 2032F, $ Billion
  • Figure 3: Global Organ Transplant Immunosuppressant Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 4: Global Organ Transplant Immunosuppressant Drugs Market, Segmentation By Transplant Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 5: Global Organ Transplant Immunosuppressant Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 6: Global Organ Transplant Immunosuppressant Drugs Market, Split By Region, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 7: Global Organ Transplant Immunosuppressant Drugs Market, Split By Country, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 8: Asia-Pacific, Organ Transplant Immunosuppressant Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 9: Asia-Pacific, Organ Transplant Immunosuppressant Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 10: China, Organ Transplant Immunosuppressant Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 11: China, Organ Transplant Immunosuppressant Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 12: India, Organ Transplant Immunosuppressant Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 13: India, Organ Transplant Immunosuppressant Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 14: Japan, Organ Transplant Immunosuppressant Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 15: Japan, Organ Transplant Immunosuppressant Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 16: Australia, Organ Transplant Immunosuppressant Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 17: Australia, Organ Transplant Immunosuppressant Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 18: Indonesia, Organ Transplant Immunosuppressant Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 19: Indonesia, Organ Transplant Immunosuppressant Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 20: South Korea, Organ Transplant Immunosuppressant Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 21: South Korea, Organ Transplant Immunosuppressant Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 22: Western Europe, Organ Transplant Immunosuppressant Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 23: Western Europe, Organ Transplant Immunosuppressant Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 24: UK, Organ Transplant Immunosuppressant Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 25: UK, Organ Transplant Immunosuppressant Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 26: Germany, Organ Transplant Immunosuppressant Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 27: Germany, Organ Transplant Immunosuppressant Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 28: France, Organ Transplant Immunosuppressant Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 29: France, Organ Transplant Immunosuppressant Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 30: Eastern Europe, Organ Transplant Immunosuppressant Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 31: Eastern Europe, Organ Transplant Immunosuppressant Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 32: Russia, Organ Transplant Immunosuppressant Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 33: Russia, Organ Transplant Immunosuppressant Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 34: North America, Organ Transplant Immunosuppressant Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 35: North America, Organ Transplant Immunosuppressant Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 36: USA, Organ Transplant Immunosuppressant Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 37: USA, Organ Transplant Immunosuppressant Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 38: South America, Organ Transplant Immunosuppressant Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 39: South America, Organ Transplant Immunosuppressant Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 40: Brazil, Organ Transplant Immunosuppressant Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 41: Brazil, Organ Transplant Immunosuppressant Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 42: Middle East, Organ Transplant Immunosuppressant Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 43: Middle East, Organ Transplant Immunosuppressant Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 44: Africa, Organ Transplant Immunosuppressant Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 45: Africa, Organ Transplant Immunosuppressant Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 46: Astellas Pharma US, Inc. Financial Performance
  • Figure 47: F. Hoffmann-La Roche AG Financial Performance
  • Figure 48: Novartis AG Financial Performance
  • Figure 49: Accord Healthcare Limited Financial Performance
  • Figure 50: GlaxoSmithKline plc. Financial Performance
View Report
View Report
View Report
View Report
View Report
View Report
View Report
View Report